Table 2 Distribution of antihypertensive substances in hypertension patients in the SHIP-0 cohort 1 to SHIP-1
From: Prevalence and determinants of controlled hypertension in a German population cohort
Females (N = 509) | Males (N = 565) | Total (N = 1074) | ||||
|---|---|---|---|---|---|---|
Active agents | N | % (95% CI 2 ) | N | % (95% CI 2 ) | N | % (95% CI 2 ) |
Beta blockers | 335 | 66.2 | 336 | 61.2 | 671 | 63.7 |
(61.8 – 70.5) | (56.8 – 65.5) | (60.6 – 66.8) | ||||
ACE-inhibitors | 252 | 49.6 | 334 | 55.3 | 586 | 52.4 |
(45.0 – 54.2) | (50.9 – 59.7) | (49.2 – 55.6) | ||||
Diuretics | 242 | 45.0 | 233 | 37.2 | 475 | 41.1 |
(40.7 – 49.4) | (32.7 – 41.7) | (38.0 – 44.3) | ||||
Calcium channel blocker | 160 | 28.9 | 187 | 32.3 | 347 | 30.6 |
(24.9 – 32.9) | (28.0 – 36.7) | (27.6 – 33.6) | ||||
Angiotensin II receptor antagonists | 108 | 20.1 | 98 | 17.3 | 206 | 18.7 |
(16.4 – 23.8) | (13.9 – 20.6) | (16.2 – 21.2) | ||||
Antiadrenergic substances 3 | 22 | 4.4 | 34 | 5.4 | 56 | 4.9 |
(2.5 – 6.3) | (3.2 – 7.7) | (3.4 – 6.4) | ||||
Vasodilators 4 | 2 | 0.3 | 1 | 0.2 | 3 | 0.2 |
(0.0 – 0.8) | (0.0 – 0.5) | (0.0 – 0.5) | ||||
Other types | - | - | 1 | 0.2 | 1 | 0.1 |
(0.0 – 0.6) | (0.0 – 0.3) | |||||